Remedy Robotics is testing the N1 remote neurointerventional system, which uses steerable catheters and computer vision algorithms to allow doctors to remotely operate a catheter to perform thrombectomy. In September 2025, the team tested the system in Toronto on 10 patients who consented to undergo non-emergency procedures, including remote operations across hospitals. The angiographic procedure was successful and took close to twice as long as the current standard. The system has not yet received full regulatory approval for remote surgery, and follow-up clinical trials will first assess on-site elective procedures before exploring remote stroke treatment.
![Remedy Robotics cofounders Jake Sganga [left] and David Bell matched energies immediately.](https://spectrum.ieee.org/media-library/remedy-robotics-cofounders-jake-sganga-left-and-david-bell-matched-energies-immediately.jpg?id=68667054&width=980)







Source:IEEE Spectrum · Read Original
Leave a Reply